Literature DB >> 32630687

Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms.

Renátó Kovács1,2, László Majoros1.   

Abstract

The number of effective therapeutic strategies against biofilms is limited; development of novel therapies is urgently needed to treat a variety of biofilm-associated infections. Quorum sensing is a special form of microbial cell-to-cell communication that is responsible for the release of numerous extracellular molecules, whose concentration is proportional with cell density. Candida-secreted quorum-sensing molecules (i.e., farnesol and tyrosol) have a pivotal role in morphogenesis, biofilm formation, and virulence. Farnesol can mediate the hyphae-to-yeast transition, while tyrosol has the opposite effect of inducing transition from the yeast to hyphal form. A number of questions regarding Candida quorum sensing remain to be addressed; nevertheless, the literature shows that farnesol and tyrosol possess remarkable antifungal and anti-biofilm effect at supraphysiological concentration. Furthermore, previous in vitro and in vivo data suggest that they may have a potent adjuvant effect in combination with certain traditional antifungal agents. This review discusses the most promising farnesol- and tyrosol-based in vitro and in vivo results, which may be a foundation for future development of novel therapeutic strategies to combat Candida biofilms.

Entities:  

Keywords:  Candida; biofilm; combination; farnesol; therapy; tyrosol

Year:  2020        PMID: 32630687     DOI: 10.3390/jof6030099

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  7 in total

1.  Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms.

Authors:  Leandro P Bezerra; Cleverson D T Freitas; Ayrles F B Silva; Jackson L Amaral; Nilton A S Neto; Rafael G G Silva; Aura L C Parra; Gustavo H Goldman; Jose T A Oliveira; Felipe P Mesquita; Pedro F N Souza
Journal:  Antibiotics (Basel)       Date:  2022-04-21

2.  The Membranotropic Peptide gH625 to Combat Mixed Candida albicans/Klebsiella pneumoniae Biofilm: Correlation between In Vitro Anti-Biofilm Activity and In Vivo Antimicrobial Protection.

Authors:  Angela Maione; Elisabetta de Alteriis; Federica Carraturo; Stefania Galdiero; Annarita Falanga; Marco Guida; Anna Di Cosmo; Valeria Maselli; Emilia Galdiero
Journal:  J Fungi (Basel)       Date:  2021-01-05

3.  Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.

Authors:  Ágnes Jakab; Noémi Balla; Ágota Ragyák; Fruzsina Nagy; Fruzsina Kovács; Zsófi Sajtos; Zoltán Tóth; Andrew M Borman; István Pócsi; Edina Baranyai; László Majoros; Renátó Kovács
Journal:  mSphere       Date:  2021-10-13       Impact factor: 4.389

4.  WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action.

Authors:  Angela Maione; Rosa Bellavita; Elisabetta de Alteriis; Stefania Galdiero; Luisa Albarano; Alessandra La Pietra; Marco Guida; Ermenegilda Parrilli; Caterina D'Angelo; Emilia Galdiero; Annarita Falanga
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

Review 5.  COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?

Authors:  Marianna Domán; Krisztián Bányai
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

Review 6.  Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?

Authors:  R Kovács; L Majoros
Journal:  Lett Appl Microbiol       Date:  2022-01-30       Impact factor: 2.813

7.  Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence.

Authors:  Andrea Ardizzoni; Giorgia Boaretto; Eva Pericolini; Diego Pinetti; Alessandra Capezzone de Joannon; Lucia Durando; Lorella Ragni; Elisabetta Blasi
Journal:  Clin Oral Investig       Date:  2022-01-23       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.